References
Mesa RA, Powell H, Lasho T, Dewald G, McClure R, Tefferi A (2006) JAK2(V617) and leukemic transformation in myelofirbrosis with myeloid metaplasia. Leuk Res 30(11):1457–1460
Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391–2405
Levine RL et al (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387–397
Zhao H, Feng J, Seidel K, Shi S, Klein O, Sharpe P, Chai Y (2014) Secretion of shh by a neurovascular bundle niche supports mesenchymal stem cell homeostasis in the adult mouse incisor. Cell Stem Cell 14(2):160–173. doi:10.1016/j.stem.2013.12.0135
Arranz L, Sánchez-Aguilera A, Martín-Pérez D, Isern J, Langa X, Tzankov A, Lundberg P, Muntión S, Tzeng YS, Lai DM, Schwaller J, Skoda RC, Méndez-Ferrer S (2014) Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature 512(7512):78–81
Statement
Ethical approval was taken from IRB.
Consent
Informed consent was obtained from all patients for being included in the study.
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bihari, C., Rastogi, A., Saxena, P. et al. Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm. Ann Hematol 94, 1427–1429 (2015). https://doi.org/10.1007/s00277-015-2396-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-015-2396-x